# A comprehensive analysis of the adverse drug events of metastatic and unresectable gastrointestinal stromal tumor treatment options: avapritinib, imatinib, regorafenib, ripretinib, and sunitinib safety insights and implications

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-comprehensive-analysis-of-the-adverse-drug-events-of-metastatic-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Cameron M. Thompson,Michael B. Andrews,Douglas G. Adler |
| Citations | 1 |
| DOI | 10.1080/20565623.2026.2672016 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/20565623.2026.2672016?needAccess=true |
| OpenAlex ID | https://openalex.org/W7161252488 |
| PMID | 42136545 |
| Type | article |
| Year | 2026 |

## Paper authors

- [Michael B. Andrews](https://scholariq.org/researchers/michael-b-andrews/)

## Paper primary topic

- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)

## Paper topics

- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Soft tissue tumors and treatment](https://scholariq.org/topics/soft-tissue-tumors-and-treatment/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.